Mia's Feed
Medical News & Research

Understanding Genetic Factors Behind Frailty in Older Adults

Understanding Genetic Factors Behind Frailty in Older Adults

Share this article

A groundbreaking study uncovers genetic variants linked to frailty in the elderly, highlighting the complex biological factors influencing aging and vulnerability in older adults.

2 min read

Recent research has uncovered significant insights into why some elderly individuals develop frailty, a condition characterized by decreased resilience and increased vulnerability to falls, infections, and other health stresses. A large-scale genetic study published in Nature Aging by scientists from Karolinska Institutet has identified multiple genetic variants linked to the development of frailty, shedding light on its biological underpinnings.

Frailty affects many older adults and is associated with higher risks of hospitalization and mortality. Understanding the genetic factors involved can help in predicting who may be at greater risk and enable earlier interventions.

The study analyzed the genomes and health data of nearly one million people from Finland and the UK, discovering hundreds of genetic markers that influence frailty. These genetic factors impact key biological systems such as immune response, brain function, and metabolic processes. Interestingly, some of these genetic variants are newly identified, emphasizing the continuous evolution of our understanding of aging.

According to lead researcher Juulia Jylhävä, associate professor at Karolinska Institutet, the findings suggest that frailty is multigenic, involving many genes that affect different bodily systems. Crucially, this genetic knowledge could pave the way for measuring an individual’s genetic risk for frailty, leading to predictive models that identify at-risk individuals earlier, possibly during middle age.

The potential for early detection opens avenues for preventative strategies aimed at delaying or mitigating frailty’s onset, thereby improving health outcomes in older populations. The research was conducted in collaboration with Tampere University in Finland.

This breakthrough signifies an important step toward personalized medicine in geriatrics, where genetic screening could become a routine part of health assessments for aging populations.

Source: medicalxpress.com

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Lipid Nanoparticles Offer Hope for Treating Rare Genetic Disease Alpha-1 Antitrypsin Deficiency

Breakthrough gene therapy using targeted lipid nanoparticles shows promising results in repairing DNA in organs affected by alpha-1 antitrypsin deficiency, offering hope for a potential cure to this rare genetic disorder.

Customized Antibiotic Dosing: Why Obesity Alters Drug Effectiveness

Emerging research reveals that obesity alters how antibiotics are processed in the body, highlighting the need for personalized dosing guidelines to improve infection treatment outcomes in obese patients.